REMINDER: Heat Biologics to Host Planned Investor and Media Livestream Event on Tuesday, April 19th at 10:30 AM ET to Discuss Latest Developments

Rhea-AI Summary

DURHAM, N.C., April 18, 2022 – Heat Biologics (NYSE American: HTBX) is hosting a livestream event on April 19, 2022, at 10:30 AM ET to discuss recent developments. Investors can join the event at this link. Heat Biologics focuses on developing innovative therapies and vaccines to modulate the immune system, featuring its gp96 platform. Ongoing projects include HS-110 in Phase 2 trials, and other immunomodulatory products in various development stages. For additional details, visit www.heatbio.com.

DURHAM, N.C., April 18, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NYSE American: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system and novel biodefense assets, reminds investors that it will host an investor and media livestream event on Tuesday, April 19, 2022 at 10:30 AM Eastern Time to discuss the latest developments. The event will be broadcast at: https://vimeo.com/event/2027558/fc6de52c31

About Heat Biologics, Inc.
Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies and vaccines to modulate the immune system. Heat’s gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in a Phase 2 trial, various infectious disease/biological threat programs in preclinical development and a pipeline of proprietary immunomodulatory antibodies and cell-based therapies, including PTX-35 and HS-130 in Phase 1 clinical trials.

For more information, please visit: www.heatbio.com, and also follow us on Twitter.

Media and Investor Relations Contact
David Waldman
+1 919 289 4017
investorrelations@heatbio.com

FAQ

What is the date and time of the Heat Biologics investor event?

The Heat Biologics investor event is on April 19, 2022, at 10:30 AM Eastern Time.

Where can I watch the Heat Biologics livestream event?

The livestream event can be watched at this link.

What is the focus of Heat Biologics as a company?

Heat Biologics focuses on developing first-in-class therapies and vaccines to modulate the immune system, particularly using its gp96 platform.

What are the current clinical trials for Heat Biologics?

Heat Biologics has HS-110 in Phase 2 trials and other candidates in Phase 1 and preclinical development.

What is the stock symbol for Heat Biologics?

The stock symbol for Heat Biologics is HTBX.